CAS 942206-85-1
:Gsk 10116790A
- GSK1016790A
- GSK1016790A;GSK-1016790A;GSK 1016790A
- CS-2774
- (N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide
- GSK-1016790A;GSK 1016790A
- N-((S)-1-(4-(((2,4-dichlorophenyl)sulfonyl)-L-seryl)piperazin-1-yl)-4-methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxamide
- GSK101
- N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
- Benzo[b]thiophene-2-carboxamide, N-[(1S)-1-[[4-[(2S)-2-[[(2,4-dichlorophenyl)sulfonyl]amino]-3-hydroxy-1-oxopropyl]-1-piperazinyl]carbonyl]-3-methylbutyl]-
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonamido)-3-hydroxypropanoyl)piperazin-1-yl)-4-methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxamide
CAS :Formule :C28H32Cl2N4O6S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :655.6129GSK1016790A
CAS :Formule :C28H32Cl2N4O6S2Degré de pureté :≥ 97%Couleur et forme :White solidMasse moléculaire :655.61GSK1016790A
CAS :GSK1016790A (GSK101) (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelialFormule :C28H32Cl2N4O6S2Degré de pureté :97.37% - 99.38%Couleur et forme :SolidMasse moléculaire :655.61Ref: TM-T6848
1mg37,00€2mg48,00€5mg72,00€10mg113,00€25mg240,00€50mg364,00€100mg540,00€1mL*10mM (DMSO)97,00€GSK 1016790A
CAS :Produit contrôléApplications GSK 1016790A is a transient receptor potential vanilloid 4 (TRPV4) agonist.
References Egbuniwe, O., et. al.: J. Dent. Res., 93, 911 (2014); Yamawaki, H., et. al.: Am. J. Phys., 307, g33 (2014)Formule :C28H32Cl2N4O6S2Couleur et forme :NeatMasse moléculaire :655.61GSK1016790A
CAS :GSK1016790A is a potent and selective small molecule inhibitor of TRPV4, a member of the transient receptor potential (TRP) channel family. It is currently being investigated for pharmacological effects in vitro and in vivo. GSK1016790A has been shown to inhibit the activity of TRPV4 channels in neuronal cells, leading to an increase in intracellular calcium levels and subsequent neuronal death. This agent also blocks the angiotensin system, which may have physiological implications including regulation of blood pressure. GSK1016790A binds to calcium binding sites on the cytosolic side of TRPV4 channels where it acts as a competitive antagonist. The compound is stable over a wide pH range and does not show any significant effect on cellular viability at concentrations up to 100 µM.
Formule :C28H32Cl2N4O6S2Degré de pureté :Min. 95%Masse moléculaire :655.61 g/mol






